世界のプロテインキナーゼ阻害剤市場インサイト及び予測(~2026年)

【英語タイトル】Global Protein Kinase Inhibitors Market Insights and Forecast to 2026

QYResearchが出版した調査資料(QYR20NV14459)・商品コード:QYR20NV14459
・発行会社(調査会社):QYResearch
・発行日:2020年11月(※2024年版があります。お問い合わせください)
・ページ数:117
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:化学・材料
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートはプロテインキナーゼ阻害剤の世界市場について調査・分析した資料です。種類別(Rx、OTC)の市場規模、用途別(病院、クリニック)の市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)の市場規模データ、主な企業情報と企業別市場シェア等が記載されています。
・調査範囲
・エグゼクティブサマリー
・企業別プロテインキナーゼ阻害剤の競争状況、市場シェア
・世界のプロテインキナーゼ阻害剤市場:種類別市場規模 2015年-2020年(Rx、OTC)
・世界のプロテインキナーゼ阻害剤市場:種類別市場規模予測 2021年-2026年(Rx、OTC)
・世界のプロテインキナーゼ阻害剤市場:用途別市場規模 2015年-2020年(病院、クリニック)
・世界のプロテインキナーゼ阻害剤市場:用途別市場規模予測 2021年-2026年(病院、クリニック)
・北米のプロテインキナーゼ阻害剤市場分析:米国、カナダ
・ヨーロッパのプロテインキナーゼ阻害剤市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアのプロテインキナーゼ阻害剤市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米のプロテインキナーゼ阻害剤市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカのプロテインキナーゼ阻害剤市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Bayer、Astra Zeneca、Roche、Teva、Apotex、Novartis、Glaxosmithkline、Pfizer
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論
【レポートの概要】

Market Analysis and Insights: Global Protein Kinase Inhibitors Market
The global Protein Kinase Inhibitors market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Protein Kinase Inhibitors Scope and Market Size
Protein Kinase Inhibitors market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Protein Kinase Inhibitors market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Protein Kinase Inhibitors market is segmented into
Rx
OTC

Segment by Application, the Protein Kinase Inhibitors market is segmented into
Hospital
Clinic

Regional and Country-level Analysis
The Protein Kinase Inhibitors market is analysed and market size information is provided by regions (countries).
The key regions covered in the Protein Kinase Inhibitors market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Protein Kinase Inhibitors Market Share Analysis
Protein Kinase Inhibitors market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Protein Kinase Inhibitors business, the date to enter into the Protein Kinase Inhibitors market, Protein Kinase Inhibitors product introduction, recent developments, etc.

The major vendors covered:
Bayer
Astra Zeneca
Roche
Teva
Apotex
Novartis
Glaxosmithkline
Pfizer

【レポートの目次】

1 Study Coverage
1.1 Protein Kinase Inhibitors Product Introduction
1.2 Market Segments
1.3 Key Protein Kinase Inhibitors Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Protein Kinase Inhibitors Market Size Growth Rate by Type
1.4.2 Rx
1.4.3 OTC
1.5 Market by Application
1.5.1 Global Protein Kinase Inhibitors Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Protein Kinase Inhibitors Market Size, Estimates and Forecasts
2.1.1 Global Protein Kinase Inhibitors Revenue 2015-2026
2.1.2 Global Protein Kinase Inhibitors Sales 2015-2026
2.2 Global Protein Kinase Inhibitors, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Protein Kinase Inhibitors Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Protein Kinase Inhibitors Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Protein Kinase Inhibitors Competitor Landscape by Players
3.1 Protein Kinase Inhibitors Sales by Manufacturers
3.1.1 Protein Kinase Inhibitors Sales by Manufacturers (2015-2020)
3.1.2 Protein Kinase Inhibitors Sales Market Share by Manufacturers (2015-2020)
3.2 Protein Kinase Inhibitors Revenue by Manufacturers
3.2.1 Protein Kinase Inhibitors Revenue by Manufacturers (2015-2020)
3.2.2 Protein Kinase Inhibitors Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Protein Kinase Inhibitors Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Protein Kinase Inhibitors Revenue in 2019
3.2.5 Global Protein Kinase Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Protein Kinase Inhibitors Price by Manufacturers
3.4 Protein Kinase Inhibitors Manufacturing Base Distribution, Product Types
3.4.1 Protein Kinase Inhibitors Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Protein Kinase Inhibitors Product Type
3.4.3 Date of International Manufacturers Enter into Protein Kinase Inhibitors Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Protein Kinase Inhibitors Market Size by Type (2015-2020)
4.1.1 Global Protein Kinase Inhibitors Sales by Type (2015-2020)
4.1.2 Global Protein Kinase Inhibitors Revenue by Type (2015-2020)
4.1.3 Protein Kinase Inhibitors Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Protein Kinase Inhibitors Market Size Forecast by Type (2021-2026)
4.2.1 Global Protein Kinase Inhibitors Sales Forecast by Type (2021-2026)
4.2.2 Global Protein Kinase Inhibitors Revenue Forecast by Type (2021-2026)
4.2.3 Protein Kinase Inhibitors Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Protein Kinase Inhibitors Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Protein Kinase Inhibitors Market Size by Application (2015-2020)
5.1.1 Global Protein Kinase Inhibitors Sales by Application (2015-2020)
5.1.2 Global Protein Kinase Inhibitors Revenue by Application (2015-2020)
5.1.3 Protein Kinase Inhibitors Price by Application (2015-2020)
5.2 Protein Kinase Inhibitors Market Size Forecast by Application (2021-2026)
5.2.1 Global Protein Kinase Inhibitors Sales Forecast by Application (2021-2026)
5.2.2 Global Protein Kinase Inhibitors Revenue Forecast by Application (2021-2026)
5.2.3 Global Protein Kinase Inhibitors Price Forecast by Application (2021-2026)

6 North America
6.1 North America Protein Kinase Inhibitors by Country
6.1.1 North America Protein Kinase Inhibitors Sales by Country
6.1.2 North America Protein Kinase Inhibitors Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Protein Kinase Inhibitors Market Facts & Figures by Type
6.3 North America Protein Kinase Inhibitors Market Facts & Figures by Application

7 Europe
7.1 Europe Protein Kinase Inhibitors by Country
7.1.1 Europe Protein Kinase Inhibitors Sales by Country
7.1.2 Europe Protein Kinase Inhibitors Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Protein Kinase Inhibitors Market Facts & Figures by Type
7.3 Europe Protein Kinase Inhibitors Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Protein Kinase Inhibitors by Region
8.1.1 Asia Pacific Protein Kinase Inhibitors Sales by Region
8.1.2 Asia Pacific Protein Kinase Inhibitors Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Protein Kinase Inhibitors Market Facts & Figures by Type
8.3 Asia Pacific Protein Kinase Inhibitors Market Facts & Figures by Application

9 Latin America
9.1 Latin America Protein Kinase Inhibitors by Country
9.1.1 Latin America Protein Kinase Inhibitors Sales by Country
9.1.2 Latin America Protein Kinase Inhibitors Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Protein Kinase Inhibitors Market Facts & Figures by Type
9.3 Central & South America Protein Kinase Inhibitors Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Protein Kinase Inhibitors by Country
10.1.1 Middle East and Africa Protein Kinase Inhibitors Sales by Country
10.1.2 Middle East and Africa Protein Kinase Inhibitors Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 UAE
10.2 Middle East and Africa Protein Kinase Inhibitors Market Facts & Figures by Type
10.3 Middle East and Africa Protein Kinase Inhibitors Market Facts & Figures by Application

11 Company Profiles
11.1 Bayer
11.1.1 Bayer Corporation Information
11.1.2 Bayer Description and Business Overview
11.1.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Bayer Protein Kinase Inhibitors Products Offered
11.1.5 Bayer Related Developments
11.2 Astra Zeneca
11.2.1 Astra Zeneca Corporation Information
11.2.2 Astra Zeneca Description and Business Overview
11.2.3 Astra Zeneca Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Astra Zeneca Protein Kinase Inhibitors Products Offered
11.2.5 Astra Zeneca Related Developments
11.3 Roche
11.3.1 Roche Corporation Information
11.3.2 Roche Description and Business Overview
11.3.3 Roche Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Roche Protein Kinase Inhibitors Products Offered
11.3.5 Roche Related Developments
11.4 Teva
11.4.1 Teva Corporation Information
11.4.2 Teva Description and Business Overview
11.4.3 Teva Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Teva Protein Kinase Inhibitors Products Offered
11.4.5 Teva Related Developments
11.5 Apotex
11.5.1 Apotex Corporation Information
11.5.2 Apotex Description and Business Overview
11.5.3 Apotex Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Apotex Protein Kinase Inhibitors Products Offered
11.5.5 Apotex Related Developments
11.6 Novartis
11.6.1 Novartis Corporation Information
11.6.2 Novartis Description and Business Overview
11.6.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Novartis Protein Kinase Inhibitors Products Offered
11.6.5 Novartis Related Developments
11.7 Glaxosmithkline
11.7.1 Glaxosmithkline Corporation Information
11.7.2 Glaxosmithkline Description and Business Overview
11.7.3 Glaxosmithkline Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Glaxosmithkline Protein Kinase Inhibitors Products Offered
11.7.5 Glaxosmithkline Related Developments
11.8 Pfizer
11.8.1 Pfizer Corporation Information
11.8.2 Pfizer Description and Business Overview
11.8.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Pfizer Protein Kinase Inhibitors Products Offered
11.8.5 Pfizer Related Developments
11.1 Bayer
11.1.1 Bayer Corporation Information
11.1.2 Bayer Description and Business Overview
11.1.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Bayer Protein Kinase Inhibitors Products Offered
11.1.5 Bayer Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Protein Kinase Inhibitors Market Estimates and Projections by Region
12.1.1 Global Protein Kinase Inhibitors Sales Forecast by Regions 2021-2026
12.1.2 Global Protein Kinase Inhibitors Revenue Forecast by Regions 2021-2026
12.2 North America Protein Kinase Inhibitors Market Size Forecast (2021-2026)
12.2.1 North America: Protein Kinase Inhibitors Sales Forecast (2021-2026)
12.2.2 North America: Protein Kinase Inhibitors Revenue Forecast (2021-2026)
12.2.3 North America: Protein Kinase Inhibitors Market Size Forecast by Country (2021-2026)
12.3 Europe Protein Kinase Inhibitors Market Size Forecast (2021-2026)
12.3.1 Europe: Protein Kinase Inhibitors Sales Forecast (2021-2026)
12.3.2 Europe: Protein Kinase Inhibitors Revenue Forecast (2021-2026)
12.3.3 Europe: Protein Kinase Inhibitors Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Protein Kinase Inhibitors Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Protein Kinase Inhibitors Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Protein Kinase Inhibitors Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Protein Kinase Inhibitors Market Size Forecast by Region (2021-2026)
12.5 Latin America Protein Kinase Inhibitors Market Size Forecast (2021-2026)
12.5.1 Latin America: Protein Kinase Inhibitors Sales Forecast (2021-2026)
12.5.2 Latin America: Protein Kinase Inhibitors Revenue Forecast (2021-2026)
12.5.3 Latin America: Protein Kinase Inhibitors Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Protein Kinase Inhibitors Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Protein Kinase Inhibitors Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Protein Kinase Inhibitors Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Protein Kinase Inhibitors Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Protein Kinase Inhibitors Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Protein Kinase Inhibitors Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Protein Kinase Inhibitors Market Segments
Table 2. Ranking of Global Top Protein Kinase Inhibitors Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Protein Kinase Inhibitors Market Size Growth Rate by Type 2020-2026 (Kiloton) & (US$ Million)
Table 4. Major Manufacturers of Rx
Table 5. Major Manufacturers of OTC
Table 6. Global Protein Kinase Inhibitors Market Size Growth Rate by Application 2020-2026 (Kiloton)
Table 7. Global Protein Kinase Inhibitors Market Size by Region (Kiloton) & (US$ Million): 2020 VS 2026
Table 8. Global Protein Kinase Inhibitors Sales by Regions 2015-2020 (Kiloton)
Table 9. Global Protein Kinase Inhibitors Sales Market Share by Regions (2015-2020)
Table 10. Global Protein Kinase Inhibitors Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Protein Kinase Inhibitors Sales by Manufacturers (2015-2020) (Kiloton)
Table 12. Global Protein Kinase Inhibitors Sales Share by Manufacturers (2015-2020)
Table 13. Global Protein Kinase Inhibitors Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Protein Kinase Inhibitors by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Protein Kinase Inhibitors as of 2019)
Table 15. Protein Kinase Inhibitors Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Protein Kinase Inhibitors Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Protein Kinase Inhibitors Price (2015-2020) (US$/Ton)
Table 18. Protein Kinase Inhibitors Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Protein Kinase Inhibitors Product Type
Table 20. Date of International Manufacturers Enter into Protein Kinase Inhibitors Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Protein Kinase Inhibitors Sales by Type (2015-2020) (Kiloton)
Table 23. Global Protein Kinase Inhibitors Sales Share by Type (2015-2020)
Table 24. Global Protein Kinase Inhibitors Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Protein Kinase Inhibitors Revenue Share by Type (2015-2020)
Table 26. Protein Kinase Inhibitors Average Selling Price (ASP) by Type 2015-2020 (US$/Ton)
Table 27. Global Protein Kinase Inhibitors Sales by Application (2015-2020) (Kiloton)
Table 28. Global Protein Kinase Inhibitors Sales Share by Application (2015-2020)
Table 29. North America Protein Kinase Inhibitors Sales by Country (2015-2020) (Kiloton)
Table 30. North America Protein Kinase Inhibitors Sales Market Share by Country (2015-2020)
Table 31. North America Protein Kinase Inhibitors Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Protein Kinase Inhibitors Revenue Market Share by Country (2015-2020)
Table 33. North America Protein Kinase Inhibitors Sales by Type (2015-2020) (Kiloton)
Table 34. North America Protein Kinase Inhibitors Sales Market Share by Type (2015-2020)
Table 35. North America Protein Kinase Inhibitors Sales by Application (2015-2020) (Kiloton)
Table 36. North America Protein Kinase Inhibitors Sales Market Share by Application (2015-2020)
Table 37. Europe Protein Kinase Inhibitors Sales by Country (2015-2020) (Kiloton)
Table 38. Europe Protein Kinase Inhibitors Sales Market Share by Country (2015-2020)
Table 39. Europe Protein Kinase Inhibitors Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Protein Kinase Inhibitors Revenue Market Share by Country (2015-2020)
Table 41. Europe Protein Kinase Inhibitors Sales by Type (2015-2020) (Kiloton)
Table 42. Europe Protein Kinase Inhibitors Sales Market Share by Type (2015-2020)
Table 43. Europe Protein Kinase Inhibitors Sales by Application (2015-2020) (Kiloton)
Table 44. Europe Protein Kinase Inhibitors Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Protein Kinase Inhibitors Sales by Region (2015-2020) (Kiloton)
Table 46. Asia Pacific Protein Kinase Inhibitors Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Protein Kinase Inhibitors Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Protein Kinase Inhibitors Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Protein Kinase Inhibitors Sales by Type (2015-2020) (Kiloton)
Table 50. Asia Pacific Protein Kinase Inhibitors Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Protein Kinase Inhibitors Sales by Application (2015-2020) (Kiloton)
Table 52. Asia Pacific Protein Kinase Inhibitors Sales Market Share by Application (2015-2020)
Table 53. Latin America Protein Kinase Inhibitors Sales by Country (2015-2020) (Kiloton)
Table 54. Latin America Protein Kinase Inhibitors Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Protein Kinase Inhibitors Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Protein Kinase Inhibitors Revenue Market Share by Country (2015-2020)
Table 57. Latin America Protein Kinase Inhibitors Sales by Type (2015-2020) (Kiloton)
Table 58. Latin America Protein Kinase Inhibitors Sales Market Share by Type (2015-2020)
Table 59. Latin America Protein Kinase Inhibitors Sales by Application (2015-2020) (Kiloton)
Table 60. Latin America Protein Kinase Inhibitors Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Protein Kinase Inhibitors Sales by Country (2015-2020) (Kiloton)
Table 62. Middle East and Africa Protein Kinase Inhibitors Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Protein Kinase Inhibitors Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Protein Kinase Inhibitors Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Protein Kinase Inhibitors Sales by Type (2015-2020) (Kiloton)
Table 66. Middle East and Africa Protein Kinase Inhibitors Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Protein Kinase Inhibitors Sales by Application (2015-2020) (Kiloton)
Table 68. Middle East and Africa Protein Kinase Inhibitors Sales Market Share by Application (2015-2020)
Table 69. Bayer Corporation Information
Table 70. Bayer Description and Major Businesses
Table 71. Bayer Protein Kinase Inhibitors Production (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2015-2020)
Table 72. Bayer Product
Table 73. Bayer Recent Development
Table 74. Astra Zeneca Corporation Information
Table 75. Astra Zeneca Description and Major Businesses
Table 76. Astra Zeneca Protein Kinase Inhibitors Production (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2015-2020)
Table 77. Astra Zeneca Product
Table 78. Astra Zeneca Recent Development
Table 79. Roche Corporation Information
Table 80. Roche Description and Major Businesses
Table 81. Roche Protein Kinase Inhibitors Production (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2015-2020)
Table 82. Roche Product
Table 83. Roche Recent Development
Table 84. Teva Corporation Information
Table 85. Teva Description and Major Businesses
Table 86. Teva Protein Kinase Inhibitors Production (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2015-2020)
Table 87. Teva Product
Table 88. Teva Recent Development
Table 89. Apotex Corporation Information
Table 90. Apotex Description and Major Businesses
Table 91. Apotex Protein Kinase Inhibitors Production (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2015-2020)
Table 92. Apotex Product
Table 93. Apotex Recent Development
Table 94. Novartis Corporation Information
Table 95. Novartis Description and Major Businesses
Table 96. Novartis Protein Kinase Inhibitors Production (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2015-2020)
Table 97. Novartis Product
Table 98. Novartis Recent Development
Table 99. Glaxosmithkline Corporation Information
Table 100. Glaxosmithkline Description and Major Businesses
Table 101. Glaxosmithkline Protein Kinase Inhibitors Production (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2015-2020)
Table 102. Glaxosmithkline Product
Table 103. Glaxosmithkline Recent Development
Table 104. Pfizer Corporation Information
Table 105. Pfizer Description and Major Businesses
Table 106. Pfizer Protein Kinase Inhibitors Production (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2015-2020)
Table 107. Pfizer Product
Table 108. Pfizer Recent Development
Table 109. Global Protein Kinase Inhibitors Sales Forecast by Regions (2021-2026) (Kiloton)
Table 110. Global Protein Kinase Inhibitors Sales Market Share Forecast by Regions (2021-2026)
Table 111. Global Protein Kinase Inhibitors Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 112. Global Protein Kinase Inhibitors Revenue Market Share Forecast by Regions (2021-2026)
Table 113. North America: Protein Kinase Inhibitors Sales Forecast by Country (2021-2026) (Kiloton)
Table 114. North America: Protein Kinase Inhibitors Revenue Forecast by Country (2021-2026) (US$ Million)
Table 115. Europe: Protein Kinase Inhibitors Sales Forecast by Country (2021-2026) (Kiloton)
Table 116. Europe: Protein Kinase Inhibitors Revenue Forecast by Country (2021-2026) (US$ Million)
Table 117. Asia Pacific: Protein Kinase Inhibitors Sales Forecast by Region (2021-2026) (Kiloton)
Table 118. Asia Pacific: Protein Kinase Inhibitors Revenue Forecast by Region (2021-2026) (US$ Million)
Table 119. Latin America: Protein Kinase Inhibitors Sales Forecast by Country (2021-2026) (Kiloton)
Table 120. Latin America: Protein Kinase Inhibitors Revenue Forecast by Country (2021-2026) (US$ Million)
Table 121. Middle East and Africa: Protein Kinase Inhibitors Sales Forecast by Country (2021-2026) (Kiloton)
Table 122. Middle East and Africa: Protein Kinase Inhibitors Revenue Forecast by Country (2021-2026) (US$ Million)
Table 123. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 124. Key Challenges
Table 125. Market Risks
Table 126. Main Points Interviewed from Key Protein Kinase Inhibitors Players
Table 127. Protein Kinase Inhibitors Customers List
Table 128. Protein Kinase Inhibitors Distributors List
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
List of Figures
Figure 1. Protein Kinase Inhibitors Product Picture
Figure 2. Global Protein Kinase Inhibitors Sales Market Share by Type in 2020 & 2026
Figure 3. Rx Product Picture
Figure 4. OTC Product Picture
Figure 5. Global Protein Kinase Inhibitors Sales Market Share by Application in 2020 & 2026
Figure 6. Hospital
Figure 7. Clinic
Figure 8. Protein Kinase Inhibitors Report Years Considered
Figure 9. Global Protein Kinase Inhibitors Market Size 2015-2026 (US$ Million)
Figure 10. Global Protein Kinase Inhibitors Sales 2015-2026 (Kiloton)
Figure 11. Global Protein Kinase Inhibitors Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Global Protein Kinase Inhibitors Sales Market Share by Region (2015-2020)
Figure 13. Global Protein Kinase Inhibitors Sales Market Share by Region in 2019
Figure 14. Global Protein Kinase Inhibitors Revenue Market Share by Region (2015-2020)
Figure 15. Global Protein Kinase Inhibitors Revenue Market Share by Region in 2019
Figure 16. Global Protein Kinase Inhibitors Sales Share by Manufacturer in 2019
Figure 17. The Top 10 and 5 Players Market Share by Protein Kinase Inhibitors Revenue in 2019
Figure 18. Protein Kinase Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Protein Kinase Inhibitors Sales Market Share by Type (2015-2020)
Figure 20. Global Protein Kinase Inhibitors Sales Market Share by Type in 2019
Figure 21. Global Protein Kinase Inhibitors Revenue Market Share by Type (2015-2020)
Figure 22. Global Protein Kinase Inhibitors Revenue Market Share by Type in 2019
Figure 23. Global Protein Kinase Inhibitors Market Share by Price Range (2015-2020)
Figure 24. Global Protein Kinase Inhibitors Sales Market Share by Application (2015-2020)
Figure 25. Global Protein Kinase Inhibitors Sales Market Share by Application in 2019
Figure 26. Global Protein Kinase Inhibitors Revenue Market Share by Application (2015-2020)
Figure 27. Global Protein Kinase Inhibitors Revenue Market Share by Application in 2019
Figure 28. North America Protein Kinase Inhibitors Sales Growth Rate 2015-2020 (Kiloton)
Figure 29. North America Protein Kinase Inhibitors Revenue Growth Rate 2015-2020 (US$ Million)
Figure 30. North America Protein Kinase Inhibitors Sales Market Share by Country in 2019
Figure 31. North America Protein Kinase Inhibitors Revenue Market Share by Country in 2019
Figure 32. U.S. Protein Kinase Inhibitors Sales Growth Rate (2015-2020) (Kiloton)
Figure 33. U.S. Protein Kinase Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Canada Protein Kinase Inhibitors Sales Growth Rate (2015-2020) (Kiloton)
Figure 35. Canada Protein Kinase Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. North America Protein Kinase Inhibitors Market Share by Type in 2019
Figure 37. North America Protein Kinase Inhibitors Market Share by Application in 2019
Figure 38. Europe Protein Kinase Inhibitors Sales Growth Rate 2015-2020 (Kiloton)
Figure 39. Europe Protein Kinase Inhibitors Revenue Growth Rate 2015-2020 (US$ Million)
Figure 40. Europe Protein Kinase Inhibitors Sales Market Share by Country in 2019
Figure 41. Europe Protein Kinase Inhibitors Revenue Market Share by Country in 2019
Figure 42. Germany Protein Kinase Inhibitors Sales Growth Rate (2015-2020) (Kiloton)
Figure 43. Germany Protein Kinase Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. France Protein Kinase Inhibitors Sales Growth Rate (2015-2020) (Kiloton)
Figure 45. France Protein Kinase Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. U.K. Protein Kinase Inhibitors Sales Growth Rate (2015-2020) (Kiloton)
Figure 47. U.K. Protein Kinase Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Italy Protein Kinase Inhibitors Sales Growth Rate (2015-2020) (Kiloton)
Figure 49. Italy Protein Kinase Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Russia Protein Kinase Inhibitors Sales Growth Rate (2015-2020) (Kiloton)
Figure 51. Russia Protein Kinase Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Europe Protein Kinase Inhibitors Market Share by Type in 2019
Figure 53. Europe Protein Kinase Inhibitors Market Share by Application in 2019
Figure 54. Asia Pacific Protein Kinase Inhibitors Sales Growth Rate 2015-2020 (Kiloton)
Figure 55. Asia Pacific Protein Kinase Inhibitors Revenue Growth Rate 2015-2020 (US$ Million)
Figure 56. Asia Pacific Protein Kinase Inhibitors Sales Market Share by Region in 2019
Figure 57. Asia Pacific Protein Kinase Inhibitors Revenue Market Share by Region in 2019
Figure 58. China Protein Kinase Inhibitors Sales Growth Rate (2015-2020) (Kiloton)
Figure 59. China Protein Kinase Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Japan Protein Kinase Inhibitors Sales Growth Rate (2015-2020) (Kiloton)
Figure 61. Japan Protein Kinase Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. South Korea Protein Kinase Inhibitors Sales Growth Rate (2015-2020) (Kiloton)
Figure 63. South Korea Protein Kinase Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. India Protein Kinase Inhibitors Sales Growth Rate (2015-2020) (Kiloton)
Figure 65. India Protein Kinase Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Australia Protein Kinase Inhibitors Sales Growth Rate (2015-2020) (Kiloton)
Figure 67. Australia Protein Kinase Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Taiwan Protein Kinase Inhibitors Sales Growth Rate (2015-2020) (Kiloton)
Figure 69. Taiwan Protein Kinase Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Indonesia Protein Kinase Inhibitors Sales Growth Rate (2015-2020) (Kiloton)
Figure 71. Indonesia Protein Kinase Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Thailand Protein Kinase Inhibitors Sales Growth Rate (2015-2020) (Kiloton)
Figure 73. Thailand Protein Kinase Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Malaysia Protein Kinase Inhibitors Sales Growth Rate (2015-2020) (Kiloton)
Figure 75. Malaysia Protein Kinase Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Philippines Protein Kinase Inhibitors Sales Growth Rate (2015-2020) (Kiloton)
Figure 77. Philippines Protein Kinase Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Vietnam Protein Kinase Inhibitors Sales Growth Rate (2015-2020) (Kiloton)
Figure 79. Vietnam Protein Kinase Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Asia Pacific Protein Kinase Inhibitors Market Share by Type in 2019
Figure 81. Asia Pacific Protein Kinase Inhibitors Market Share by Application in 2019
Figure 82. Latin America Protein Kinase Inhibitors Sales Growth Rate 2015-2020 (Kiloton)
Figure 83. Latin America Protein Kinase Inhibitors Revenue Growth Rate 2015-2020 (US$ Million)
Figure 84. Latin America Protein Kinase Inhibitors Sales Market Share by Country in 2019
Figure 85. Latin America Protein Kinase Inhibitors Revenue Market Share by Country in 2019
Figure 86. Mexico Protein Kinase Inhibitors Sales Growth Rate (2015-2020) (Kiloton)
Figure 87. Mexico Protein Kinase Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Brazil Protein Kinase Inhibitors Sales Growth Rate (2015-2020) (Kiloton)
Figure 89. Brazil Protein Kinase Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Argentina Protein Kinase Inhibitors Sales Growth Rate (2015-2020) (Kiloton)
Figure 91. Argentina Protein Kinase Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Latin America Protein Kinase Inhibitors Market Share by Type in 2019
Figure 93. Latin America Protein Kinase Inhibitors Market Share by Application in 2019
Figure 94. Middle East and Africa Protein Kinase Inhibitors Sales Growth Rate 2015-2020 (Kiloton)
Figure 95. Middle East and Africa Protein Kinase Inhibitors Revenue Growth Rate 2015-2020 (US$ Million)
Figure 96. Middle East and Africa Protein Kinase Inhibitors Sales Market Share by Country in 2019
Figure 97. Middle East and Africa Protein Kinase Inhibitors Revenue Market Share by Country in 2019
Figure 98. Turkey Protein Kinase Inhibitors Sales Growth Rate (2015-2020) (Kiloton)
Figure 99. Turkey Protein Kinase Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Saudi Arabia Protein Kinase Inhibitors Sales Growth Rate (2015-2020) (Kiloton)
Figure 101. Saudi Arabia Protein Kinase Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. UAE Protein Kinase Inhibitors Sales Growth Rate (2015-2020) (Kiloton)
Figure 103. UAE Protein Kinase Inhibitors Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Middle East and Africa Protein Kinase Inhibitors Market Share by Type in 2019
Figure 105. Middle East and Africa Protein Kinase Inhibitors Market Share by Application in 2019
Figure 106. North America Protein Kinase Inhibitors Sales Growth Rate Forecast (2021-2026) (Kiloton)
Figure 107. North America Protein Kinase Inhibitors Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 108. Europe Protein Kinase Inhibitors Sales Growth Rate Forecast (2021-2026) (Kiloton)
Figure 109. Europe Protein Kinase Inhibitors Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 110. Asia Pacific Protein Kinase Inhibitors Sales Growth Rate Forecast (2021-2026) (Kiloton)
Figure 111. Asia Pacific Protein Kinase Inhibitors Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Latin America Protein Kinase Inhibitors Sales Growth Rate Forecast (2021-2026) (Kiloton)
Figure 113. Latin America Protein Kinase Inhibitors Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Middle East and Africa Protein Kinase Inhibitors Sales Growth Rate Forecast (2021-2026) (Kiloton)
Figure 115. Middle East and Africa Protein Kinase Inhibitors Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Porter's Five Forces Analysis
Figure 117. Channels of Distribution
Figure 118. Distributors Profiles
Figure 119. Bottom-up and Top-down Approaches for This Report
Figure 120. Data Triangulation
Figure 121. Key Executives Interviewed


【掲載企業】

Bayer、Astra Zeneca、Roche、Teva、Apotex、Novartis、Glaxosmithkline、Pfizer

★調査レポート[世界のプロテインキナーゼ阻害剤市場インサイト及び予測(~2026年)] (コード:QYR20NV14459)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のプロテインキナーゼ阻害剤市場インサイト及び予測(~2026年)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆